ARC Ento Tech

Transaction Summary

Investment Highlights

Company Overview

The ARC Process™ consists of processes that are used to recover, re-form and re-purpose all mixed unsegregated waste components.

From the recovery of nutrients from the organic waste components to the conversion of plastic waste into hydrogen and industrial carbon, this technology forms the foundation for real solutions to global waste challenges.

The technology utilises an innovative approach to waste recovery and upcycling and is protected under a patent pending.

Strong business model that meets the 3 pillars of sustainability – People, Planet, Profit.

Collaborations with 3 universities on further research that will enhance value.

Three pending grant applications with both the NSW and Federal Governments on a research grant for hydrogen recovery as well as commercialisation of the ARC process for recovering waste plastic

Arc Ento Tech was incorporated in Australia in Feb 2020 after conducting proof of concept trials overseas. Its focus is on the use of insects to recover nutrients from organic waste and combining with a novel approach to recovering and converting all plastic waste into viable commercial products.

The company has established both markets and clients for the sale and supply of waste, as well as waste derived products and is ready to commercialise the first set of plants.

This is leading edge technology that will change the landscape of waste processing around the world. Following on from the demonstration and initial start-up plants there are already discussions to construct and operate at least seven full scale plants as early as 2024 with overseas expansion following shortly after.

Transaction Overview

Series 2A Capital Raising of A$5M with a pre-money valuation of A$20M.

Offering 2 million Class A shares at A$2.50 per share.

Team

Management